Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccinees and breakthrough infected individuals

Despite SARS-CoV-2 vaccines eliciting systemic neutralising antibodies (nAbs), breakthrough infections still regularly occur. Infection helps to generate mucosal immunity, possibly reducing disease transmission. Monitoring mucosal nAbs is predominantly restricted to lab-based assays, which have limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Chee Wah, Lim, Chuan Kok, Prestedge, Jacqueline, Batty, Mitchell, Mah, Yun Yan, O’Han, Michelle, Wang, Lin-Fa, Kilby, Dean, Anderson, Danielle E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662396/
https://www.ncbi.nlm.nih.gov/pubmed/37985674
http://dx.doi.org/10.1038/s41598-023-47613-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662396/
https://www.ncbi.nlm.nih.gov/pubmed/37985674
http://dx.doi.org/10.1038/s41598-023-47613-8

Ejemplares similares